Experiment 480801

Worktypes

PHARMACOLOGY OF COMPOUND - IN HUMANS

Compounds isolated

QUINOLINE,ISO:

Details

PropertyValue
Pharmacology
ANTIPSORIATIC ACTIVITY
Administration routeEXTERNAL
OrganismEmpty organism
CitationARNOLD,WP: GLADE,CP: MIER,PD: VAN DE KERKHOF,PCM:. (1993). EFFECTS OF SPHINGOSINE, ISOQUINOLINE AND TANNIC ACID ON THE HUMAN TAPE-STRIPPING MODEL AND THE PSORIATIC LESION.. 6(3)
Amount utilized
Compound isolated
Disease17 PSORIATIC PATIENTS WERE ENROLLED IN STUDY. NO SIDE EFFECTS WERE NOTED. COMPOUND APPLIED TWICE DAILY FOR 12 DAYS.
Dose amount0.2%
Number2
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE